Sacristán, Daniel <br/><br/>
Effects of coronary prestenting platelet inhibition on coronary poststenting inflammation.  [electronic resource] 

 -  Journal of cardiovascular pharmacology  Mar 2008 
 - 286-92 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0160-2446 
<br/><br/><label>Standard No.: </label>10.1097/FJC.0b013e318163a90f  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Clopidogrel<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Inflammation--etiology<br/>Infusions, Intravenous<br/>Male<br/>Myocardial Infarction--therapy<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Platelet Glycoprotein GPIIb-IIIa Complex<br/>Stents--adverse effects<br/>Ticlopidine--administration & dosage<br/>Time Factors<br/>Tirofiban<br/>Tyrosine--administration & dosage<br/>alpha 1-Antitrypsin--drug effects